glp-1 drugs news today like Ozempic linked to slower cancer spread, study finds Once people understood glucagonlike peptide
Description
Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells
The plaintiffs allege that drugmaker Novo Nordisk didn't warn them about the risks of taking the medication
New research suggests GLP-1 drugs could reduce cancer risk
The FDA has also warned about risks during surgery because the drug slows digestion
Includes PREDIMED data and EU health claim context.
Gila monster research helped spawn recent medications for diabetes and weight loss like Ozempic
